Pfizer (PFE) Work In Process (2009 - 2019)

Pfizer (PFE) has 11 years of Work In Process data on file, last reported at $5.2 billion in Q1 2019.

• Work In Process for Q1 2019 came in at $5.2 billion, up 15.54% year-over-year; the trailing twelve-month figure through Mar 2019 was $5.2 billion (up 15.54% YoY), and the FY2018 annual result was $4.7 billion, up 20.29% from the prior year.
• Work In Process climbed to $5.2 billion in Q1 2019 per PFE's latest filing, from $4.7 billion in the prior quarter.
• Over five years, Work In Process peaked at $5.2 billion in Q1 2019 and troughed at $3.4 billion in Q1 2015.
• A 5-year average of $4.2 billion and a median of $4.0 billion in 2016 frame the typical range for Work In Process.
• The sharpest annual moves came in 2015 and 2016: Work In Process advanced 21.06% in 2015, then dropped 6.0% in 2016.
• A 5-year view of Work In Process shows it stood at $3.9 billion in 2015, then dropped by 6.0% to $3.7 billion in 2016, then gained by 5.74% to $3.9 billion in 2017, then climbed by 20.29% to $4.7 billion in 2018, then gained by 10.23% to $5.2 billion in 2019.
• Business Quant data shows PFE's Work In Process at $5.2 billion in Q1 2019, $4.7 billion in Q4 2018, and $4.8 billion in Q3 2018.